Cargando…
Recent Advances in CRISPR/Cas9-Based Genome Editing Tools for Cardiac Diseases
In the past two decades, genome editing has proven its value as a powerful tool for modeling or even treating numerous diseases. After the development of protein-guided systems such as zinc finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs), which for the first time...
Autores principales: | Schreurs, Juliët, Sacchetto, Claudia, Colpaert, Robin M. W., Vitiello, Libero, Rampazzo, Alessandra, Calore, Martina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537312/ https://www.ncbi.nlm.nih.gov/pubmed/34681646 http://dx.doi.org/10.3390/ijms222010985 |
Ejemplares similares
-
Modeling Cardiovascular Diseases with hiPSC-Derived Cardiomyocytes in 2D and 3D Cultures
por: Sacchetto, Claudia, et al.
Publicado: (2020) -
Recent Advances in Genome Editing Using CRISPR/Cas9
por: Ding, Yuduan, et al.
Publicado: (2016) -
MicroRNAs in Cardiac Diseases
por: Colpaert, Robin M.W., et al.
Publicado: (2019) -
Recent Advances in CRISPR/Cas9-Mediated Genome Editing in Dictyostelium
por: Muramoto, Tetsuya, et al.
Publicado: (2019) -
CRISPR-Cas9: Tool for Qualitative and Quantitative Plant Genome Editing
por: Noman, Ali, et al.
Publicado: (2016)